Bladder Cancer
Diagnosis and Clinical Management
by Seth P. Lerner, Mark P. Schoenberg, Cora N. Sternberg
1st Edition
Publisher: John Wiley & Sons, Ltd.
Book Details
| Print ISBN | 9781118674840 |
| eText ISBN | 9781118674857 |
| Publisher | John Wiley & Sons, Ltd. |
| Publishing Year | 2015 |
| Edition | 1st Edition |
| Language | English |
Bladder Cancer: Diagnosis and Clinical Management, 1st Edition, is a clinical reference book dedicated to evaluating and managing urothelial malignancies. The volume maintains a direct clinical focus rather than emphasizing basic science or pathogenesis.
Core subject areas include diagnostic methods, urine biomarkers, and imaging alongside both drug therapies and surgical interventions across disease stages. Coverage spans non-muscle-invasive bladder cancer, radical cystectomy, and systemic chemotherapy regimens.
Practicing urologists and oncologists will find clinical management algorithms and guidelines from ASCO, the AUA, ESMO, and the EAU. Each chapter is illustrated in full color and includes concise practical tips to assist clinicians in selecting individualized treatment programs.
Table of Contents
Chapter 1: Pathology
Chapter 2: Risk stratification of high-grade Ta, CIS, and T1 urothelial carcinoma of the bladder
Chapter 3: Utility of urine biomarkers
Chapter 4: Novel endoscopic techniques for the detection of bladder cancer
Chapter 5: Transurethral resection of bladder tumors
Chapter 6: Intravesical chemotherapy
Chapter 7: Intravesical immunotherapy
Chapter 8: HGT1 bladder cancer: Diagnosis and treatment
Chapter 9: What to do when bacillus Calmette-Guérin fails
Chapter 10: Selection and perioperative management of patients undergoing radical cystectomy and urinary reconstruction
Chapter 11: Radical cystectomy: Techniques and outcomes
Chapter 12: Cystectomy in the female patient
Chapter 13: Laparoscopic/robotic radical cystectomy and urinary diversion: Outcomes
Chapter 14: Robotic assisted radical cystectomy and urinary diversion: Clinical trials
Chapter 15: Role of extended lymphadenectomy
Chapter 16: Management of the urethra in the cystectomy patient
Chapter 17: The role of radical cystectomy in patients with unresectable or regionally metastatic urothelial carcinoma of the bladder
Chapter 18: Radical transurethral resection
Chapter 19: Partial cystectomy
Chapter 20: Integrating chemotherapy and radiotherapy for bladder cancer
Chapter 21: Orthotopic neobladder
Chapter 22: Continent cutaneous diversion
Chapter 23: Non-continent urinary diversion
Chapter 24: Molecular determinants of chemotherapy response
Chapter 25: Neoadjuvant chemotherapy in the treatment of muscle-invasive bladder cancer
Chapter 26: Adjuvant chemotherapy for invasive bladder cancer
Chapter 27: Treatment of metastatic bladder cancer
Chapter 28: Treatment of poor risk patients
Chapter 29: Molecular events in muscle-invasive bladder cancer development
Chapter 30: Cancer stem cells and intrinsic subtypes in bladder cancer
Chapter 31: Multi-targeted agents in the treatment of urothelial carcinoma
Chapter 32: Patient navigation and cancer navigator programs
Chapter 33: Impact of health services on compliance and outcomes
Chapter 34: Quality of life and survivorship
Chapter 35: Bladder cancer: Healthcare delivery and third party payers
Chapter 36: Bladder cancer patient advocacy: Creating partnerships to advance patient care, research, and clinical trials
Customer Reviews
0.0
0 reviews
No reviews yet. Be the first to review this book!
Write a Review
Reviewed by GradeFocus Editorial Team
Related Books
Nanotheranostics and Precision Oncology
Ramish Riaz
Ovarian Cancer
Bhupendra G. Prajapati
Artificial Intelligence for Enhanced Diagnosis in Oncology
Ashwin Kotnis
Artificial Intelligence in Gastrointestinal Cancers
Ganji Purnachandra Nagaraju
Bladder Cancer Breakthroughs
Bhupendra G. Prajapati
Emerging Trends in Cancer Pharmacology
Tapan Behl